logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Biodrugs 封面图

Biodrugs

IF6.9
论文数1683
被引数3462
期刊论文 1683
发表时间
delete
Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users银屑病、银屑病关节炎和/或其他脊柱关节炎患者发生主要心血管事件的风险：一项包含72,291名生物制剂新用户的队列研究
deleteBiodrugs
IF6.9
delete2026-10-30
delete0
PREAI
deleteLaetitia Penso; Mounya Abboud; Mahmoud Zureik; Emilie Sbidian
delete分享
delete收藏
Sustained Efficacy and Safety of Mirikizumab Through 152 Weeks in Chinese Patients with Moderately to Severely Active Crohn’s Disease: A Subpopulation Analysis of the VIVID-1 and VIVID-2 Phase 3 Trials中国中重度活动性克罗恩病患者中mirikizumab长达152周的持续疗效与安全性：VIVID-1和VIVID-2 III期试验的亚组分析
deleteBiodrugs
IF6.9
delete2026-10-28
delete0
PREAI
deleteXiang Gao; Qian Cao; Xiaowei Liu; Baili Chen; Wenjia Liu; Wen Tang; Yufang Wang; Jie Zhong; Zhaotao Li; Xiaoyan Wang; Yi Sun; Prashant Gupta; Jiao Yu; Jiawei Xu; Minhu Chen
delete分享
delete收藏
Correction: Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field纠正：靶向细菌感染的单克隆抗体：该领域的广泛综述
deleteBiodrugs
IF6.9
delete2026-10-27
delete0
deleteOAAI
deleteMatthew J. Slarve; Christine Tkaczyk; Michael P. Doyle; Timothy J. Break; Alexander B. Smith; Galit Alter; Brian Luna; Brad Spellberg; Antonio DiGiandomenico
delete分享
delete收藏
IL-6 Blockade for Antibody-Mediated Transplant Rejection: What Does the Evidence Say?IL-6阻断在抗体介导的移植排斥反应中的应用：证据表明了什么？
deleteBiodrugs
IF6.9
delete2026-10-23
delete0
PREAI
deleteMehmet Kanbay; Sidar Copur; Can Altunbulakli; Zeynep B. Eren; Ibrahim Gulmaliyev; Nur I. Genc; Caner Süsal; Adrian Covic; Mahmut Altindal
delete分享
delete收藏
Incidence and Risk Factors of Treatment-Emergent Eczematous Reactions in Patients with Psoriasis Treated with Biologics: A Systematic Review and Meta-Analysis银屑病患者使用生物制剂治疗后新发湿疹样反应的发生率及危险因素：一项系统评价和Meta分析
deleteBiodrugs
IF6.9
delete2026-10-16
delete0
PREAI
deleteYifei Feng; Yan Lu
delete分享
delete收藏
From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate从反思到实施：一种培美曲塞生物类似物的定制化临床开发
deleteBiodrugs
IF6.9
delete2026-09-19
delete0
deleteOAAI
deleteBjörn Capsius; Marija Pesic; Ravil Niyazov; Susanne Pippig; Michael Trieb; Rahul Hole; Sigrid Balser; Andreas Seidl
delete分享
delete收藏
Plant-Based Systems for Producing Therapeutic Proteins: Current Status and Future Prospects植物基系统生产治疗性蛋白质：现状与未来展望
deleteBiodrugs
IF6.9
delete2026-09-17
delete0
PREAI
deleteQiang Chen
delete分享
delete收藏
HLX11: A Pertuzumab BiosimilarHLX11：一种帕妥珠单抗生物类似药
deleteBiodrugs
IF6.9
delete2026-09-17
delete0
PREAI
deleteAisling McGuigan
delete分享
delete收藏
Biosimilars: A Virtuous Cycle of Sustainability and Innovation生物类似药：可持续性与创新的一个良性循环
deleteBiodrugs
IF6.9
delete2026-09-14
delete0
deleteOAAI
deleteFernando de Mora; Vicente Merino-Bohórquez; Rosario García-Vicuña; Isabel Río-Álvarez
delete分享
delete收藏
Beyond the Prevention of Anti-drug Antibody Formation with Uricase Therapy: Mechanistic Roles of DMARDs in Modifying Gout Flare Risk超越尿酸酶疗法预防抗药抗体形成：改善痛风发作风险的DMARDs机制作用
deleteBiodrugs
IF6.9
delete2026-09-14
delete0
deleteOAAI
deleteTed R. Mikuls; Tuhina Neogi; Angelo Gaffo
delete分享
delete收藏
Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases溶酶体贮积症中缓解神经退行性变的生物疗法
deleteBiodrugs
IF6.9
delete2026-09-14
delete0
deleteOAAI
deleteLiyan Qiu; Jonas Torbjörn Ungerbäck; Eric Paul Bennett; Rasmus O. Bak
delete分享
delete收藏
The Effect of Anti-drug Antibodies on the Bioavailability of Alglucosidase Alfa in Classic Infantile Pompe Disease抗药抗体对经典婴儿型庞贝病中阿糖苷酶alfa生物利用度的影响
deleteBiodrugs
IF6.9
delete2026-09-11
delete0
deleteOAAI
deleteMartha Caterina Faraguna; Daniël A. M. Lambregts; Ina Barzel; Edwin H. Jacobs; Marianne Hoogeveen-Westerveld; Nadine A. M. E. van der Beek; W. W. M. Pim Pijnappel; Serena Gasperini; Tim Preijers; Johanna M. P. van den Hout; Ans T. van der Ploeg
delete分享
delete收藏
Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability靶向MYC驱动的癌症：从致癌成瘾到治疗易损性
deleteBiodrugs
IF6.9
delete2026-09-02
delete0
deleteOAAI
deleteLourdes Sainero-Alcolado; Dilraj Lama; Mohammad Alzrigat; Marie Arsenian-Henriksson
delete分享
delete收藏
Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial比较放射学轴性脊柱关节炎伴既往急性前葡萄膜炎患者中阿达木单抗与皮下注射英夫利昔单抗诱发急性前葡萄膜炎复发的风险：一项随机对照试验
deleteBiodrugs
IF6.9
delete2026-08-28
delete0
PREAI
deleteOh Chan Kwon; Soo Min Ahn; Seokchan Hong; Yeon Hong Seo; Min Kim; Joo Yong Lee; Un Chul Park; Seong Joon Ahn; Min-Chan Park; Eun Young Lee; Tae-Hwan Kim; Yong-Gil Kim
delete分享
delete收藏
Targeting CD38 Across Autoimmune and Plasma Cell–Driven Immune-Mediated Diseases: Rationale, Clinical Evidence, and Emerging Therapeutic Landscape靶向CD38在自身免疫和浆细胞驱动的免疫介导性疾病中的应用：理论基础、临床证据及新兴治疗格局
deleteBiodrugs
IF6.9
delete2026-08-18
delete0
deleteOAAI
deleteDario Roccatello; Savino Sciascia; Daniela Rossi; Roberta Fenoglio
delete分享
delete收藏
Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study银屑病患者在完成12周应答指导的司库奇尤单抗治疗后停药的临床结局：一项前瞻性真实世界队列研究
deleteBiodrugs
IF6.9
delete2026-08-03
delete0
PREAI
deleteXin Ma; Yue Jiang; Dongmei Liu; Quanruo Xu; Fanlingzi Shen; Zhen Duan; Xiangjin Gao; Xiuqi Zhang; Ruiqi Cai; Rui Zhang; Bin Li; Ruiping Wang
delete分享
delete收藏
Population Pharmacokinetic Comparability of CT-P16 Versus EU-Avastin® and US-Avastin® in Healthy Subjects and Patients with Non-Squamous Non-Small Cell Lung CancerCT-P16与欧盟和美国的阿瓦斯汀®在健康受试者与非鳞状非小细胞肺癌患者中的群体药代动力学可比性比较
deleteBiodrugs
IF6.9
delete2026-08-02
delete0
deleteOAAI
deleteTaekyung Kim; Heungjo Kim; Hongjae Lee; Keumyoung Ahn; Taehong Park; Hyungseok Baek; Min Jung Chang
delete分享
delete收藏
Expanding Patient Access to Advanced Therapies扩大患者对先进疗法的可及性
deleteBiodrugs
IF6.9
delete2026-07-21
delete0
deleteOAAI
deleteElena Guillen; Ana Hidalgo-Simon
delete分享
delete收藏
Home Infusion With Recombinant Human α-Glucosidase in Children With Pompe Disease: The Dutch Experience Over 20 Years Across the Spectrum From Classic Infantile to Late-Onset Phenotypes重组人α-葡萄糖苷酶在庞贝病儿童中的家庭输注：荷兰20年经验，涵盖从经典婴儿型到迟发型表型的全谱系
deleteBiodrugs
IF6.9
delete2026-07-20
delete0
deleteOAAI
deleteImke A. M. Ditters; Hidde H. Huidekoper; Jacqueline F. Hardon; Michelle E. Kruijshaar; Ans T. van der Ploeg; Johanna M. P. van den Hout
delete分享
delete收藏
Why Product Drift Is Not an Issue for Biosimilars/Biologics: Start the Same, Stay the Same为何产品漂移并非生物类似药/生物药的问题：起始相同，保持一致
deleteBiodrugs
IF6.9
delete2026-07-08
delete0
deleteOAAI
deleteJoseph P. Park; Hyunhee Oh; Gillian R. Woollett
delete分享
delete收藏